Literature DB >> 16751005

Tryptase genetics and anaphylaxis.

George H Caughey1.   

Abstract

Tryptases secreted by tissue mast cells and basophils can enter the bloodstream. In human subjects tryptases are encoded by several genes and alleles, including alpha, beta, gamma, and delta. Common variations include complete absence of alpha genes. Until recently, alpha tryptase was considered to be the major tryptase secreted at baseline and in mastocytosis. However, lack of alpha tryptase genes has little effect on circulating tryptase levels, which are now thought mainly to consist of inactive pro-beta tryptase secreted constitutively rather than stored in granules with mature tryptases. Pro-beta tryptase levels thus might reflect total body mast cell content. In contrast, mature beta tryptase can increase transiently in severe systemic anaphylaxis and confirm the diagnosis. However, it might fail to increase in food anaphylaxis or might increase nonspecifically in samples acquired after death. Thus pro- and mature beta tryptase measurements are useful but associated with false-negative and false-positive results, which need to be considered in drawing clinical conclusions in cases of suspected anaphylaxis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16751005      PMCID: PMC2271076          DOI: 10.1016/j.jaci.2006.02.026

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  25 in total

1.  Mast cell tryptase potentiates histamine-induced contraction in human sensitized bronchus.

Authors:  P R Johnson; A J Ammit; S M Carlin; C L Armour; G H Caughey; J L Black
Journal:  Eur Respir J       Date:  1997-01       Impact factor: 16.671

2.  Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis.

Authors:  L B Schwartz; J W Yunginger; J Miller; R Bokhari; D Dull
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

3.  Quantitation of histamine, tryptase, and chymase in dispersed human T and TC mast cells.

Authors:  L B Schwartz; A M Irani; K Roller; M C Castells; N M Schechter
Journal:  J Immunol       Date:  1987-04-15       Impact factor: 5.422

4.  A novel heparin-dependent processing pathway for human tryptase. Autocatalysis followed by activation with dipeptidyl peptidase I.

Authors:  K Sakai; S Ren; L B Schwartz
Journal:  J Clin Invest       Date:  1996-02-15       Impact factor: 14.808

5.  Insect-sting challenge in 138 patients: relation between clinical severity of anaphylaxis and mast cell activation.

Authors:  P W van der Linden; C E Hack; J Poortman; Y C Vivié-Kipp; A Struyvenberg; J K van der Zwan
Journal:  J Allergy Clin Immunol       Date:  1992-07       Impact factor: 10.793

6.  Human mast cell tryptase: multiple cDNAs and genes reveal a multigene serine protease family.

Authors:  P Vanderslice; S M Ballinger; E K Tam; S M Goldstein; C S Craik; G H Caughey
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

7.  Inhaled tryptase causes bronchoconstriction in sheep via histamine release.

Authors:  J F Molinari; M Scuri; W R Moore; J Clark; R Tanaka; W M Abraham
Journal:  Am J Respir Crit Care Med       Date:  1996-09       Impact factor: 21.405

8.  Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis.

Authors:  L B Schwartz; D D Metcalfe; J S Miller; H Earl; T Sullivan
Journal:  N Engl J Med       Date:  1987-06-25       Impact factor: 91.245

9.  Human mast cell tryptase activates single-chain urinary-type plasminogen activator (pro-urokinase).

Authors:  M S Stack; D A Johnson
Journal:  J Biol Chem       Date:  1994-04-01       Impact factor: 5.157

10.  Release of the mucosal mast cell granule chymase, rat mast cell protease-II, during anaphylaxis is associated with the rapid development of paracellular permeability to macromolecules in rat jejunum.

Authors:  C L Scudamore; E M Thornton; L McMillan; G F Newlands; H R Miller
Journal:  J Exp Med       Date:  1995-12-01       Impact factor: 14.307

View more
  38 in total

Review 1.  Postmortem chemistry update part II.

Authors:  Cristian Palmiere; Patrice Mangin
Journal:  Int J Legal Med       Date:  2011-10-09       Impact factor: 2.686

Review 2.  Approaches for analyzing the roles of mast cells and their proteases in vivo.

Authors:  Stephen J Galli; Mindy Tsai; Thomas Marichal; Elena Tchougounova; Laurent L Reber; Gunnar Pejler
Journal:  Adv Immunol       Date:  2015-02-07       Impact factor: 3.543

Review 3.  Mast cell tryptases and chymases in inflammation and host defense.

Authors:  George H Caughey
Journal:  Immunol Rev       Date:  2007-06       Impact factor: 12.988

Review 4.  Hereditary Alpha-Tryptasemia: a Commonly Inherited Modifier of Anaphylaxis.

Authors:  Richard Wu; Jonathan J Lyons
Journal:  Curr Allergy Asthma Rep       Date:  2021-05-10       Impact factor: 4.806

Review 5.  Mast cell peptidases: chameleons of innate immunity and host defense.

Authors:  Neil N Trivedi; George H Caughey
Journal:  Am J Respir Cell Mol Biol       Date:  2009-11-20       Impact factor: 6.914

Review 6.  Peri-operative anaphylaxis.

Authors:  Linda Nel; Efrem Eren
Journal:  Br J Clin Pharmacol       Date:  2011-05       Impact factor: 4.335

Review 7.  Mast cell proteases as pharmacological targets.

Authors:  George H Caughey
Journal:  Eur J Pharmacol       Date:  2015-05-07       Impact factor: 4.432

Review 8.  Anaphylaxis as a clinical manifestation of clonal mast cell disorders.

Authors:  A Matito; I Alvarez-Twose; J M Morgado; L Sánchez-Muñoz; A Orfao; L Escribano
Journal:  Curr Allergy Asthma Rep       Date:  2014-08       Impact factor: 4.806

Review 9.  [Anaphylaxis. Clinical manifestations and diagnosis].

Authors:  B Przybilla; J Ring; F Ruëff
Journal:  Hautarzt       Date:  2007-12       Impact factor: 0.751

10.  Food allergy in adults: an over- or underrated problem?

Authors:  Cornelia S Seitz; Petra Pfeuffer; Petra Raith; Eva-B Bröcker; Axel Trautmann
Journal:  Dtsch Arztebl Int       Date:  2008-10-17       Impact factor: 5.594

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.